Skip to Main Content
12 Jun 26
12 Jun 26
12 Jun 26
12 Jun 26
Introduction
Services Offered
Vision Mission & Value
Management Team
Our Membership
Life Insurance
General Insurance
Mutual Funds
Foreign Exchange
RTA
Tax Management
Equity Trading
Commodity Trading
Digital Signature
FD & Bonds
E-Insurance
PAN TAN E-Filing & KYC
Equity
Commodity
Derivatives
Currency
IPO
Mutual Funds
Daily Market Tracker
Top Gainers & Losers
Top Value & Volume
52 Week High/Low
Advances & Declines
New Highs & Lows
Corporate Information
Detailed Quotes
Company Snapshot
Company Background
Board of Directors
Directors Report
Balance Sheet
Profit & loss
Cash Flow
Quarterly Results
Key Financial Ratios
Peer Comparison
Share Price
Company News
Corporate Actions
BSE Announcements
NSE Announcements
Board Meetings
Book Closure
Bonus Issues
Rights Issues
Delisted Shares
Market Turnover
Change Of Name
Split Of Face Value
Other Markets
ADR Prices
Forex
FII Investment
MF Investment
World Indices
News
Pre-Session
Mid-Session
End-Session
Market Beat
Stock Alert
Corporate Results
Foreign Markets
Economy News
Corporate News
Other Markets
Hot Pursuit
Currency News
Insurance
Tax Management
Markets > Equity > News > Economy News >
Detailed News
Your Result On : News | Economy News | Detailed News
Back
India targets USD 50 billion pharmaceutical exports by 2030
10-Jun-2026 11:26 Hrs IST
Ministry of Commerce & Industry stated in a latest update that India's pharmaceutical exports have increased from about USD 14 billion in FY 2014-15 to about USD 31 billion in FY 2025-26, with medicines reaching patients in more than 200 countries. He added that while India continues to maintain its leadership in generic medicines, the sector is increasingly moving towards innovation-driven growth. Commerce Secretary Rajesh Agrawal outlined India's goal of achieving USD 50 billion in pharmaceutical exports by 2030 through quality, innovation, regulatory excellence and market diversification. He noted that India has more than 10,500 manufacturing units and over 60,000 generic brands across 60 therapeutic categories. Agrawal further highlighted that over 60 per cent of India's pharmaceutical exports are destined for highly regulated markets, reflecting growing international confidence in India's pharmaceutical manufacturing capabilities and quality standards.
Powered by
Capital Market - Live News
Owned by Radhey IT Solution Pvt. Ltd
Reg. Office: Tobacco House, 1,Old Court House Corner, 5th Floor, Suite No.514, 519, 520 & 521. Kolkata-700001 Tel: 033 2231 9012
Disclaimer
|
Privacy Policy
|
Scores
|
BSE
|
NSE
|
SEBI
|
RBI
|
Sitemap
|
Feedback
|
ODR Platform
Sanjeevani Insurance Brokers Pvt. Ltd.
IRDA DB-273/04
Sabi Viniyog Pvt. Ltd.
RBI-FE.KOL.MC/02-2006
SEBI(RTA)-INR000004025
ARN No-29109
Ramsnehi Viniyog Pvt. Ltd.
MCX/TCM/CORP/1246
MCX-31335
SEBI Regn. No. INZ000046331
Seemran Viniyog Pvt. Ltd.
INB 241264135
Jhilmil Advisoy & Accounting
Services Pvt. Ltd.
Local Registration Authority of Digital Signature
Copyright © 2013 All rights Reserved Radhey Group Of Companies Designed, Developed and Maintained by
CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)